Gilead Sciences (GILD)

Gilead Sciences (GILD) Stock Price & Analysis


GILD Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$72.54 - $86.75
Previous Close$77.65
Average Volume (3M)5.74M
Market Cap
Enterprise Value$120.51B
Total Cash (Recent Filing)$1.16B
Total Debt (Recent Filing)$24.98B
Price to Earnings (P/E)16.6
Feb 06, 2024
Share Statistics
EPS (TTM)4.66
Shares Outstanding1,246,041,895
10 Day Avg. Volume5,846,268
30 Day Avg. Volume5,738,289
Standard Deviation0.07
Financial Highlights & Ratios
Price to Book (P/B)-7.36
Price to Sales (P/S)3.55
Price to Cash Flow (P/CF)9.80
P/FCF Ratio9.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.41
Enterprise Value/Gross Profit5.57
Enterprise Value/Ebitda11.27
Price Target Upside14.51% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering18



Ownership Overview

29.80% Mutual Funds
50.59% Other Institutional Investors
18.94% Public Companies and Individual Investors


What was Gilead Sciences’s price range in the past 12 months?
Gilead Sciences lowest stock price was $72.54 and its highest was $86.75 in the past 12 months.
    What is Gilead Sciences’s market cap?
    Currently, no data Available
    When is Gilead Sciences’s upcoming earnings report date?
    Gilead Sciences’s upcoming earnings report date is Feb 06, 2024 which is in 63 days.
      How were Gilead Sciences’s earnings last quarter?
      Gilead Sciences released its earnings results on Nov 07, 2023. The company reported $2.29 earnings per share for the quarter, beating the consensus estimate of $1.916 by $0.374.
        Is Gilead Sciences overvalued?
        According to Wall Street analysts Gilead Sciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Gilead Sciences pay dividends?
          Gilead Sciences pays a Quarterly dividend of $0.75 which represents an annual dividend yield of 3.84%. See more information on Gilead Sciences dividends here
            What is Gilead Sciences’s EPS estimate?
            Gilead Sciences’s EPS estimate is $1.79.
              How many shares outstanding does Gilead Sciences have?
              Gilead Sciences has 1,246,041,900 shares outstanding.
                What happened to Gilead Sciences’s price movement after its last earnings report?
                Gilead Sciences reported an EPS of $2.29 in its last earnings report, beating expectations of $1.916. Following the earnings report the stock price went down -3.362%.
                  Which hedge fund is a major shareholder of Gilead Sciences?
                  Among the largest hedge funds holding Gilead Sciences’s share is Dodge & Cox. It holds Gilead Sciences’s shares valued at 3B.


                    Company Description

                    Gilead Sciences

                    Founded in 1987, California-based Gilead Sciences, Inc. is a biopharmaceutical company, which focuses on the research, development, and commercialization of antiviral drugs used in the treatment of diseases like human immunodeficiency virus (HIV), hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi. It offers its products under brands including Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi.


                    Top 5 ETFs holding GILD

                    Market Value
                    Smart Score
                    Global X S&P 500 Covered Call ETF
                    Zacks Earnings Consistent Portfolio ETF
                    iShares ESG Screened S&P 500 ETF
                    Global X S&P 500 Covered Call & Growth ETF
                    Global X S&P 500 ESG Covered Call ETF
                    Up to five ETFs with an Outperform Smart Score that hold GILD. The ETFs are listed according to market value of GILD within the ETF

                    Forecast EPS vs Actual EPS

                    Similar Stocks
                    Price & Change
                    Merck & Company

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis